We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SNDX market cap is 1.78B. The company's latest EPS is USD -2.4641 and P/E is -8.35.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -35.14M | -42.03M | -46.02M | -49.68M | -56.36M |
Net Income | -35.4M | -39.19M | -41.13M | -44.62M | -51.15M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.52M | 1.52M | 139.71M | 0 | 0 |
Operating Income | -57.54M | -71.42M | 26.22M | -151.76M | -229.95M |
Net Income | -56.05M | -73.16M | 24.93M | -149.34M | -209.36M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 359.69M | 497.24M | 459.83M | 431.34M | 399.22M |
Total Liabilities | 21.59M | 29.79M | 24.32M | 31.3M | 40.04M |
Total Equity | 338.1M | 467.45M | 435.51M | 400.04M | 359.19M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 63.53M | 300.61M | 449.66M | 497.24M | 612.88M |
Total Liabilities | 31.93M | 48.43M | 41.29M | 29.79M | 58.68M |
Total Equity | 31.6M | 252.19M | 408.37M | 467.45M | 554.2M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -110.78M | -133.68M | -39.23M | -74.6M | -119.25M |
Investing | -48.56M | -186.19M | 19.92M | 93.82M | 133.9M |
Financing | 8.75M | 172.25M | 2.47M | 3.8M | 5.65M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -50.61M | -71.26M | 29.13M | -133.68M | -160.6M |
Investing | 12.78M | -142.53M | -40.87M | -186.19M | 117.61M |
Financing | 28.57M | 304.42M | 118.46M | 172.25M | 264.13M |
Market Cap | 1.78B |
Price to Earnings Ratio | -8.35 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5.92 |
Price to Book Ratio | 3.15 |
Dividend Yield | - |
Shares Outstanding | 84.97M |
Average Volume (1 week) | 686.52k |
Average Volume (1 Month) | 889.24k |
52 Week Change | -0.47% |
52 Week High | 25.34 |
52 Week Low | 11.215 |
Spread (Intraday) | 0.09 (0.43%) |
Company Name | Syndax Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.syndax.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions